• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Lorillard

Lorillard

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Foundation Arm of BI-LO , Harveys and Winn-Dixie Donates More Than $3.1 Million to 225 Charities Throughout Southeast

    Foundation Arm of BI- LO , Harveys and Winn-Dixie Donates More Than $3.1 Million to 225 Charities Throughout Southeast

  2. Reynolds, Lorillard Shareholders to Vote Jan. 28 on $25 Billion Merger

    Reynolds, Lorillard Shareholders to Vote Jan. 28 on $25 Billion Merger

  3. Fitch: Smoke Clearing on U.S. Regulation and Tobacco Consolidation in 2015

    Fitch: Smoke Clearing on U.S. Regulation and Tobacco Consolidation in 2015

  4. Enanta Announces U.S. Food and Drug Administration Approves AbbVie’s VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C ...

    Enanta Announces U.S. Food and Drug Administration Approves AbbVie’s VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C Virus

  5. SoundHound Reveals Top Songs, Artists and Albums of 2014

    SoundHound Reveals Top Songs, Artists and Albums of 2014

  6. Reynolds American Finance Chief to Retire

    Reynolds American Finance Chief to Retire

  7. China's Pain, U.S.'s Gain

    Slower growth in China will likely mean lower commodity prices--which, in turn, could stimulate the U.S. economy, says Morningstar's Bob Johnson.

  8. Slacker Unveils Redesign, Rolls Out the Future of Radio: Personalized Radio & a Platform for Creators

    Slacker Unveils Redesign, Rolls Out the Future of Radio: Personalized Radio & a Platform for Creators

  9. 9 New Names Join the Wide Moat Focus Index

    Some energy names and out-of-favor companies joined the index, but, in a sign of the times, few deeply discounted stocks.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.